뒤로
Duality Biotherapeutics, Inc.(09606.HK) 가격
09606.HK 주가 차트
DUALITYBIO-B (09606.HK)
Duality Biotherapeutics, Inc.
HK$347.4
-3.92%
$-14.2
장 종료: Jan 20, 16:00:00 HKT
주요 통계
이전 종가
$355
시가
$361.6
일일 범위
$344.4 - $370.8
52주 범위
$165.5 - $563.5
거래량
645.3K
평균 거래량
1.2M
EPS(TTM)
-35.78
배당수익률
--
시가총액
$30.5B
DUALITYBIO-B란 무엇인가요?
Duality Biotherapeutics, Inc. operates as a clinical stage company. The company is headquartered in Shanghai, Shanghai and currently employs 191 full-time employees. The company went IPO on 2025-04-15. The firm is dedicated to the development of antibody-drug conjugate (ADC) innovative therapeutics to treat cancer and autoimmune diseases. The firm's primary drug product candidates include DB-1303/BNT323, DB-1311/BNT324, DB-1310, DB-1305/BNT325, DB-1419 and DB-2304. The firm's products are mainly used for the targeted treatment of endometrial cancer (EC), breast cancer (BC), small-cell lung cancer (SCLC), castration-resistant prostate cancer (CRPC), esophageal squamous cell carcinoma (ESCC), as well as head and neck squamous cell carcinoma (HNSCC). The firm principally conducts its businesses in domestic and overseas markets.